Cyclo(Arg-Pro) TFA

Immunoaffinity-based positive/negative selection without magnetic or flow cytometric separation is implemented as immunopanning, in which dissociated cells bind to antibody-coated plastic surfaces through specific cell-surface antigens; negative-selection plates remove unwanted antigen-positive cells, and positive-selection plates retain the desired antigen-positive population for recovery and downstream culture or analysis. The readout is the recovered cell fraction after sequential plate binding and washing: depleted non-adherent cells represent the negative-selection output, while cells retained on the final antibody-coated surface represent the positive-selection output; published examples include T-cell subpopulation purification, mouse and rat oligodendrocyte-lineage cell isolation, and mouse marrow progenitor enrichment.

Density gradient centrifugation enriches cells by buoyant density: cells sediment during centrifugation until they reach a medium layer or interface compatible with their density, allowing mononuclear cells, granulocytes, erythrocytes, and density-defined subpopulations to be recovered from separate bands or layers. Classic blood-cell applications include Ficoll/sodium-metrizoate or Ficoll-Hypaque enrichment of peripheral blood mononuclear cells, Percoll subfractionation of PBMC and T-cell populations, and Percoll-based neutrophil isolation from whole blood or leukocyte-enriched suspensions. The readout is the physical recovery of enriched cell bands, followed by cell counting, morphology, viability, and immunophenotyping to determine yield, purity, and suitability for downstream assays.

Cell counting and cell-density analysis estimate the number of cells in a known volume or field area. Manual hemocytometer counting uses a chamber of defined geometry to convert counted cells into cells/mL, while automated counters and image-analysis workflows detect cell objects from optical, brightfield, fluorescence, impedance, or digital-image features. Trypan blue viability counting is based on dye exclusion: viable cells with intact membranes exclude dye, while non-viable cells with compromised membranes stain blue. The readout is total cell density, viable-cell density, dead-cell density, and percent viability. Cell density can also be estimated from microscopy images by counting objects per image area, from flow cytometry using calibrated volume or reference particles, or from in situ microscopy in bioreactors after calibration against reference methods such as hemocytometer or flow cytometry.

Microfluidic cell sorting separates target cells in microscale channels by either intrinsic physical properties or specific molecular binding. Label-free platforms use size, deformability, hydrodynamic behavior, acoustic contrast, dielectric properties, or inertial migration to alter cell trajectories without antibody labeling, while affinity-based platforms immobilize antibodies, selectins, aptamers, or ligand-bearing nanoparticles to capture cells expressing corresponding surface markers. Classic label-free examples include deterministic lateral displacement arrays, inertial focusing systems, acoustophoresis devices, dielectrophoresis systems, and physical cluster-capture devices. Classic affinity-based examples include EpCAM-coated micropost or herringbone chips, PSMA-GEDI devices, E-selectin/anti-EpCAM biomimetic surfaces, and nanoparticle-mediated capture-and-release chips.

A method of simulating the in vivo environment in vitro to maintain the cell growth, differentation and main functions.

Dielectrophoresis-based electrical cell sorting separates suspended cells by the motion generated when polarizable cells experience a non-uniform electric field; cell trajectory depends on cell size, medium conductivity, applied AC frequency, electric-field gradient, and cell dielectric properties, so cells with different DEP responses can be routed, trapped, levitated, or released without biochemical labeling. In practical DEP sorters, the readout is the spatial redistribution of cells into different outlets, traps, or recovered fractions; reported examples include DEP field-flow fractionation of leukocytes, breast cancer cells, CD34+ cells, and blood cells, continuous-flow hMSC/osteoblast sorting, and image-based single-cell recovery after DEP manipulation.

The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.

Cell counting-based growth curve assays quantify cell proliferation by directly measuring changes in viable cell number over time using manual or automated counting methods such as hemocytometer-based counting or instrument-assisted cell enumeration, enabling construction of growth curves that reflect population expansion dynamics in response to culture conditions. A widely used approach is trypan blue exclusion with hemocytometer counting, where membrane-compromised (non-viable) cells take up the dye, allowing discrimination between viable and non-viable cells while simultaneously enabling total cell number quantification. Repeated sampling across time points allows estimation of proliferation rate, growth phases, and comparative growth kinetics between experimental conditions.

MACS enriches or depletes cells by binding antibody-targeted magnetic particles to surface antigens; labeled cells are retained in a high-gradient magnetic column, while unlabeled cells pass through, and retained cells are eluted after removal from the magnetic field. In ovalbumin-induced allergic airway inflammation, MACS can enrich immune populations such as CD4+ T cells, CD8+ T cells, dendritic cells, eosinophils, or marker-defined leukocytes for downstream analysis of airway inflammation, antigen presentation, and type 2 immune responses.

The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.

The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.